Articles related to POISONING/OVERDOSE

This case underscores the importance of considering occupational exposure in patients presenting with unexplained neurologic symptoms. The patient’s history as a welder without personal protective equipment was key to diagnosing manganese poisoning – a reminder that sometimes the workplace can be a source of insidious health hazards.

Stay informed about the increasing prevalence of xylazine in illegally manufactured fentanyl. Learn about its impact on patient care and discover strategies for effective treatment and harm reduction.

The alarming findings on nitazenes’ impact on cardiac arrest rates and naloxone dosage requirements demand your attention; further details could change how we approach opioid overdose treatments.

SIVAD Diagnostic Medical Group’s novel drug testing strips, HarmGuard FX, are making strides in harm reduction, beginning in Delaware. These strips, a part of the wider Harm Stopper Program, signal a potential turning point in the battle against the national opioid crisis.

According to the FDA, more than 101,000 fatal overdoses were reported during the 12-month period that ended in October 2022. Nearly half of fatal overdoses involve bystanders, but naloxone is only used in a small percentage of those situations. According to medical professionals who support the approval, there would be a critical opportunity to close this gap and lower the number of opioid-related deaths if naloxone were available over-the-counter.

There is no readily available test for xylazine and narcotic antagonists are ineffective. Overdosage is characterized by sedation and unresponsiveness. When combined with fentanyl, overdose symptoms can include blue-to-grayish skin, slowed breathing and bradycardia.